Literature DB >> 2178559

Cyclosporine. An immunosuppressant affecting epithelial cell proliferation.

J Kanitakis1, J Thivolet.   

Abstract

Cyclosporine (cyclosporin A) is an immunosuppressant that selectively acts on the CD4+ subset of T lymphocytes. Recent results of experimental in vitro and in vivo studies, as well as evidence obtained through the clinical use of cyclosporine in humans, strongly suggest that cyclosporine may exert a direct effect on the growth of several epithelial cell types. Thus, cyclosporine, while stimulating the growth of hair follicle keratinocytes with a resulting hypertrichosis, appears to exert a cytostatic effect on several epithelial cell types of human and animal origin. This antiproliferative effect is shared by some minimally immunosuppressive or nonimmunosuppressive cyclosporine analogues, suggesting that the molecular mechanisms that modulate epithelial cell growth differ from those responsible for immunosuppression. This newly discovered pharmacologic property of cyclosporine may hopefully lead to the wider use of nonimmunosuppressive cyclosporines in the treatment of hyperproliferative epidermal diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178559     DOI: 10.1001/archderm.126.3.369

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Erythromelalgia induced by possible calcium channel blockade by ciclosporin.

Authors:  Gurvinder P Thami; Mala Bhalla
Journal:  BMJ       Date:  2003-04-26

2.  Histological and ultrastructural effects of cyclosporin A on normal human skin xenografted on to nude mice.

Authors:  J Kanitakis; A Ramirez-Bosca; M Haftek; J Thivolet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Kidney Diseases: The Age of Molecular Markers.

Authors:  Glaucia Luciano da Veiga; Beatriz da Costa Aguiar Alves; Matheus Moreira Perez; Joyce Regina Raimundo; Jéssica Freitas de Araújo Encinas; Neif Murad; Fernando Luiz Affonso Fonseca
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Cyclosporine is angiostatic.

Authors:  K Norrby
Journal:  Experientia       Date:  1992-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.